(Q50777705)

English

CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.

scientific article published on 21 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

Massimiliano Castellazzi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

Enrico Granieri

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

author name string

E Fainardi

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

R Rizzo

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

L Melchiorri

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

M Stignani

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

C Tamborino

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

E Paolino

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

M R Tola

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

O R Baricordi

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

publication date

21 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

14

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

446-454

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

Multiple sclerosis--the plaque and its pathogenesis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

HLA-G in the nervous system

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

HLA-G: a shield against inflammatory aggression

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Intrathecal synthesis of soluble class I antigens in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Biology and functions of human leukocyte antigen-G in health and sickness

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085137

21 January 2018

Identifiers

10.1177/1352458507085137

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/18208868

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50777705&oldid=780759219"